167 related articles for article (PubMed ID: 16149130)
1. Over-expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma.
Qiu WH; Zhou BS; Chu PG; Chen WG; Chung C; Shih J; Hwu P; Yeh C; Lopez R; Yen Y
World J Gastroenterol; 2005 Sep; 11(34):5266-72. PubMed ID: 16149130
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.
Qiu W; David D; Zhou B; Chu PG; Zhang B; Wu M; Xiao J; Han T; Zhu Z; Wang T; Liu X; Lopez R; Frankel P; Jong A; Yen Y
Am J Pathol; 2003 Jun; 162(6):1961-74. PubMed ID: 12759252
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.
Gómez-Román JJ; Saenz P; Molina M; Cuevas González J; Escuredo K; Santa Cruz S; Junquera C; Simón L; Martínez A; Gutiérrez Baños JL; López-Brea M; Esparza C; Val-Bernal JF
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):459-65. PubMed ID: 15701828
[TBL] [Abstract][Full Text] [Related]
4. Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing.
Yan X; Shao C; Chen C; Chen J; Gu S; Huang L; Fu X; Zhao H; Qiu Y
Dig Dis Sci; 2017 Feb; 62(2):407-417. PubMed ID: 28058595
[TBL] [Abstract][Full Text] [Related]
5. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal relationship in gene expression between FGFR1 and FGFR3: implication for tumorigenesis.
Jang JH
Oncogene; 2005 Jan; 24(5):945-8. PubMed ID: 15558020
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma.
Zhu L; Somlo G; Zhou B; Shao J; Bedell V; Slovak ML; Liu X; Luo J; Yen Y
Mol Cancer Ther; 2005 May; 4(5):787-98. PubMed ID: 15897243
[TBL] [Abstract][Full Text] [Related]
8. Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma.
Tsou AP; Wu KM; Tsen TY; Chi CW; Chiu JH; Lui WY; Hu CP; Chang C; Chou CK; Tsai SF
Genomics; 1998 Jun; 50(3):331-40. PubMed ID: 9676427
[TBL] [Abstract][Full Text] [Related]
9. Expression of fibroblast growth factor receptor 3 by fibroblast growth factor 2 in cultured chick embryo chondrocytes.
Suh JY; Kim YS; Park JW; Sonn JK; Kim WT
Cell Biol Int; 2005 Mar; 29(3):203-12. PubMed ID: 15878293
[TBL] [Abstract][Full Text] [Related]
10. Ribozyme cleavage leads to decreased expression of fibroblast growth factor receptor 3 in human multiple myeloma cells, which is associated with apoptosis and downregulation of vascular endothelial growth factor.
Qian S; Somlo G; Zhou B; Zhu L; Mi S; Mo X; Cheung EM; Qiu W; Lin RJ; Rossi J; Holtz M; Chu P; Yen Y
Oligonucleotides; 2005; 15(1):1-11. PubMed ID: 15788896
[TBL] [Abstract][Full Text] [Related]
11. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
12. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
13. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.
Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T
World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
15. Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor.
Fujii T; Koshikawa K; Nomoto S; Okochi O; Kaneko T; Inoue S; Yatabe Y; Takeda S; Nakao A
J Hepatol; 2004 Jul; 41(1):104-11. PubMed ID: 15246215
[TBL] [Abstract][Full Text] [Related]
16. Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.
van Rhijn BW; Vis AN; van der Kwast TH; Kirkels WJ; Radvanyi F; Ooms EC; Chopin DK; Boevé ER; Jöbsis AC; Zwarthoff EC
J Clin Oncol; 2003 May; 21(10):1912-21. PubMed ID: 12743143
[TBL] [Abstract][Full Text] [Related]
17. FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation.
Liu X; Jing X; Cheng X; Ma D; Jin Z; Yang W; Qiu W
Med Oncol; 2016 May; 33(5):46. PubMed ID: 27044356
[TBL] [Abstract][Full Text] [Related]
18. EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma.
Cha YL; Li PD; Yuan LJ; Zhang MY; Zhang YJ; Rao HL; Zhang HZ; Zheng XF; Wang HY
PLoS One; 2015; 10(2):e0117493. PubMed ID: 25658620
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
20. The significance of fibroblast growth factor receptor 2 expression in differentiation of hepatocellular carcinoma.
Harimoto N; Taguchi K; Shirabe K; Adachi E; Sakaguchi Y; Toh Y; Okamura T; Kayashima H; Taketomi A; Maehara Y
Oncology; 2010; 78(5-6):361-8. PubMed ID: 20798558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]